ENZ Enzo Biochem Inc.

Enzo Biochem to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, October 13

Enzo Biochem to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, October 13
EN
06/10/2020

Underlying

ENZEnzo Biochem Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Enzo Biochem Inc.

 PRESS RELEASE
Free
ENZ Enzo Biochem In...

Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Tran...

Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder Value Farmingdale, NY, June 24, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced that on June 23, 2025, following the market close, it entered into an Agreement and Plan of Merger (the “Merger Agreement”) to be acquired by Battery Ventures, a global, technology-focused investment firm, through its newly formed entity Bethpage Parent, Inc. ...

June 24, 2025 1 EN
 PRESS RELEASE
Free
ENZ Enzo Biochem In...

Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results

Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2025. Financial Highlights The Company’s third-quarter revenue of $6.4 million declined by $1.6 million or 20% compared to the same period in the prior year across all geographic areas. This is due to general continued headwinds in the life sciences tools space, including decreases in government grants, reduced R&D budgets, and tariffs unce...

June 16, 2025 1 EN
 PRESS RELEASE
Free
ENZ Enzo Biochem In...

Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Re...

Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash Preservation and Near-Term Initiatives to Enhance Value Farmingdale, NY, April 22, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced that its Board of Directors ...

April 22, 2025 1 EN
 PRESS RELEASE
Free
ENZ Enzo Biochem In...

Enzo Biochem Announces Notification to New York Stock Exchange of Inte...

Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quoted on the OTCQX Best Market (“OTCQX”). Enzo provided notice of the voluntary delisting to the NYSE on March 28, 2025 and intends to timely file a notification of removal from listing on ...

March 28, 2025 1 EN
 PRESS RELEASE
Free
ENZ Enzo Biochem In...

Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results

Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal second quarter ended January 31, 2025, with sequential quarter improvement in revenue, gross margin and operating profit / loss. Financial Highlights The Company’s second-quarter gross margin percentage of 52% increased sequentially from 37% during Q1 2025 and increased from 49% during the second quarter of the prior year. These improvements were driven by change in re...

March 17, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch